Clinical Trial Update: Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating Utidelone capsules in combination with fluoropyrimidine- and platinum-containing therapy as first-line treatment for gastr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Utidelone (utidelone)

Snippet

Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd. | Conditions: Gastric or Gastroesophageal Junction Adenocarcinoma | Phase 2, Phase 3 | Status: RECRUITING